GLP-1 Coverage Shrinking on ACA Marketplaces

In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, breaks down CMS’ proposed 2027 Medicare Advantage rule, challenges facing smaller MA plans, and the shrinking access to GLP-1 medications on ACA marketplaces. He also highlights the evolving dynamics between payers, providers and consumers as policy and costs rapidly shift.